Short description
Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.
Description
Biointaxis is a genomic treatment and technology development company. The current lead program develops a gene therapy treatment for Friedreich ataxia, a rare, inherited, progressive neurodegenerative disease that typically affects teenagers and young adults. They reestablished the neurological functions in mice models of friedreich ataxia.
Total funding
$$2020202
Sign in for full access
Location
Barcelona, Catalonia, Spain, Europe
Founded on
July 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Founders
Antoni Matilla Dueñas, Ivelisse Sanchez